Cancer Biomarkers for Integrative Oncology

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Current Oncology Reports

• Publication date

  2019-03-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11912-019-0782-6PMID 30834992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein kinase C activator bryostatin‐1 modulates proteasome function

  2018cited by this paper
• Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol

  2017cited by this paper
• Curcumin mediates anticancer effects by modulating multiple cell signaling pathways.

  2017cited by this paper
• Disease Subtype–Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A

  2017cited by this paper
• Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin

  2017cited by this paper
• Deceptive curcumin offers cautionary tale for chemists

  2017cited by this paper
• Chapter 2 - Natural Products as Lead Protein Kinase C Modulators for Cancer Therapy

  2016cited by this paper
• The Ben Cao Gang Mu: Chinese Edition

  2016cited by this paper
• Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway

  2016cited by this paper
• Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN)

  2016cited by this paper
• Honokiol targets mitochondria to halt cancer progression and metastasis.

  2016cited by this paper
• PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment

  2015cited by this paper
• Targeting NF-κB Signaling with Protein Kinase C Agonists As an Emerging Strategy for Combating HIV Latency

  2015cited by this paper
• Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy

  2015cited by this paper
• Sulforaphane Bioavailability and Chemopreventive Activity in Women Scheduled for Breast Biopsy

  2015cited by this paper
• Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract.

  2015cited by this paper
• Cruciferous Vegetables, Isothiocyanates, and Prevention of Bladder Cancer

  2015cited by this paper
• Keap1–Nrf2 pathway: A promising target towards lung cancer prevention and therapeutics

  2015cited by this paper
• A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer

  2015cited by this paper
• The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018)

  2014cited by this paper
• Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.

  2014cited by this paper
• Honokiol inhibits epithelial—mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E‐cadherin axis

  2014cited by this paper
• Sulforaphane inhibits the proliferation of the BIU87 bladder cancer cell line via IGFBP-3 elevation.

  2014cited by this paper
• Isothiocyanate metabolism, distribution, and interconversion in mice following consumption of thermally processed broccoli sprouts or purified sulforaphane.

  2014cited by this paper
• Sulforaphane induces apoptosis in T24 human urinary bladder cancer cells through a reactive oxygen species-mediated mitochondrial pathway: the involvement of endoplasmic reticulum stress and the Nrf2 signaling pathway.

  2014cited by this paper
• Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination.

  2013cited by this paper
• Sulforaphane: translational research from laboratory bench to clinic.

  2013cited by this paper
• Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane.

  2013cited by this paper
• Inhibition of bladder cancer by broccoli isothiocyanates sulforaphane and erucin: characterization, metabolism, and interconversion.

  2012cited by this paper
• Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy.

  2012cited by this paper
• Sulforaphane Induces Cell Cycle Arrest and Apoptosis in Acute Lymphoblastic Leukemia Cells

  2012cited by this paper
• Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research.

  2012cited by this paper
• Bioavailability of Sulforaphane from Two Broccoli Sprout Beverages: Results of a Short-term, Cross-over Clinical Trial in Qidong, China

  2011cited by this paper
• A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer.

  2011cited by this paper
• Total synthesis of bryostatin 1.

  2011cited by this paper
• Phenethyl Isothiocyanate Inhibits 12-O-Tetradecanoylphorbol-13-Acetate-Induced Inflammatory Responses in Mouse Skin

  2011cited by this paper
• Intake of Cruciferous Vegetables Modifies Bladder Cancer Survival

  2010cited by this paper
• Chemotherapy: the four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity

  2010cited by this paper
• Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS).

  2010cited by this paper
• Allyl isothiocyanate as a cancer chemopreventive phytochemical.

  2010cited by this paper
• Biomarkers in bladder cancer

  2010cited by this paper
• Biomarkers in bladder cancer

  2010cited by this paper
• Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies.

  2010cited by this paper
• A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906

  2010cited by this paper
• Phase II study of PHY906 plus capecitabine (CAP) in pts with gemcitabine-refractory pancreatic cancer (PC) and measurement of cytokines.

  2010cited by this paper
• A phase I study of PHY906 as a modulator of irinotecan (CPT-11) in patients with advanced solid tumors.

  2010cited by this paper
• Phase I/II study of PHY906/capecitabine in advanced hepatocellular carcinoma.

  2009cited by this paper
• Mammalian MCM Loading in Late-G1 Coincides with Rb Hyperphosphorylation and the Transition to Post-Transcriptional Control of Progression into S-Phase

  2009cited by this paper
• Cell Cycle Arrest by Transforming Growth Factor β1 near G1/S Is Mediated by Acute Abrogation of Prereplication Complex Activation Involving an Rb-MCM Interaction

  2009cited by this paper
• Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6

  2009cited by this paper
• Sulforaphane down-regulates COX-2 expression by activating p38 and inhibiting NF-kappaB-DNA-binding activity in human bladder T24 cells.

  2009cited by this paper
• Broccoli Consumption Interacts with GSTM1 to Perturb Oncogenic Signalling Pathways in the Prostate

  2008cited by this paper
• Consumption of Raw Cruciferous Vegetables is Inversely Associated with Bladder Cancer Risk

  2008cited by this paper
• Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.

  2008cited by this paper
• Curcumin induces cell‐arrest and apoptosis in association with the inhibition of constitutively active NF‐κB and STAT3 pathways in Hodgkin's lymphoma cells

  2008cited by this paper
• Liquid chromatography/mass spectrometry analysis of PHY906, a Chinese medicine formulation for cancer therapy.

  2007cited by this paper
• D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1.

  2007cited by this paper
• Sulforaphane as a promising molecule for fighting cancer.

  2007cited by this paper
• Apoptotic and proliferation indexes in primary superficial bladder tumors.

  2006cited by this paper
• The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells

  2006cited by this paper
• Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli.

  2005cited by this paper
• Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent.

  2005cited by this paper
• The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells.

  2004cited by this paper
• Induction of phase II detoxification enzymes in rats by plant-derived isothiocyanates: comparison of allyl isothiocyanate with sulforaphane and related compounds.

  2004cited by this paper
• Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells.

  2004cited by this paper
• Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder.

  2003cited by this paper
• Phase I/IIA randomized study of PHY906, a novel herbal agent, as a modulator of chemotherapy in patients with advanced colorectal cancer.

  2003cited by this paper
• STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1.

  2003cited by this paper
• Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in Vivo*

  2003cited by this paper
• Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans.

  2002cited by this paper
• Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism.

  2001cited by this paper
• Risk of Bladder Cancer by Geographic Region in a U.S. Cohort of Male Health Professionals

  2001cited by this paper
• Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells.

  2000cited by this paper
• Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men.

  2000cited by this paper
• Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort.

  1999cited by this paper
• Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables.

  1998cited by this paper
• A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.

  1995cited by this paper
• A phase I study of intravenous bryostatin 1 in patients with advanced cancer.

  1993cited by this paper
• A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure.

  1992cited by this paper
• Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.

  1992cited by this paper

• Exploring Key Biomarkers in Canine Cutaneous Squamous Cell Carcinoma

  2025cites this paper
• Integrated single-cell and spatial transcriptomics uncover the prognostic, epigenetic, and immunological roles of FANCC in low-grade glioma.

  2025cites this paper
• A critical assessment of Traditional Chinese Medicine databases as a source for drug discovery

  2024cites this paper
• Immunohistochemical Expression Levels of Epidermal Growth Factor Receptor, Cyclooxygenase-2, and Ki-67 in Canine Cutaneous Squamous Cell Carcinomas

  2024cites this paper
• Editorial: Volume II: Tumor microenvironment in cancer hallmarks and therapeutics

  2023cites this paper
• NPCDR: natural product-based drug combination and its disease-specific molecular regulation

  2021cites this paper
• Pre- and Post-harvest Factors Affecting Glucosinolate Content in Broccoli

  2020cites this paper